Literature DB >> 2092348

Frozen and fresh Anaplasma centrale vaccines in the protection of cattle against Anaplasma marginale infection.

A A Abdala1, E Pipano, D H Aguirre, A B Gaido, M A Zurbriggen, A J Mangold, A A Guglielmone.   

Abstract

The immunity induced by frozen and fresh Anaplasma centrale vaccines against anaplasmosis caused by A. marginale was tested in 12-month old Friesian steers. A. centrale parasitaemia occurred in all cattle inoculated with both types of vaccine. The average maximal decrease in PCV for the frozen and fresh vaccines was 41.0 and 40.3% respectively. All cattle recovered spontaneously. Vaccinated and control steers of the same age were challenged six months later with doses of 10(6), 10(7) or 10(8) A. marginale organisms. Vaccinated cattle showed average maximal A. marginale parasitemia of 1.2-4.0 versus 10.3-12.0% in control cattle. The average maximal decrease in packed cell volume (PCV) was 33.1 and 30.0% for steers vaccinated with frozen or fresh vaccine, respectively, and 57.4% for the non-vaccinated steers. All vaccinated cattle recovered spontaneously from the A. marginale infection while 7 out of 8 control steers required specific treatment. It thus appears that both frozen and fresh A. centrale vaccines are equally capable of inducing partial protection against infection with A. marginale and of preventing severe red blood cell destruction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2092348

Source DB:  PubMed          Journal:  Rev Elev Med Vet Pays Trop        ISSN: 0035-1865


  9 in total

1.  Analysis of the 16S rRNA gene sequence of Anaplasma centrale and its phylogenetic relatedness to other ehrlichiae.

Authors:  H Inokuma; Y Terada; T Kamio; D Raoult; P Brouqui
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

Review 2.  Antigens and alternatives for control of Anaplasma marginale infection in cattle.

Authors:  Katherine M Kocan; José de la Fuente; Alberto A Guglielmone; Roy D Meléndez
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

3.  Expression and immune recognition of the conserved MSP4 outer membrane protein of Anaplasma marginale.

Authors:  S M Oberle; G H Palmer; A F Barbet
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

4.  Susceptibility to different tick genera in Gambian N'Dama and Gobra zebu cattle exposed to naturally occurring tick infestations.

Authors:  R C Mattioli; M Bah; S Kora; M Cassama; D J Clifford
Journal:  Trop Anim Health Prod       Date:  1995-05       Impact factor: 1.559

5.  Protective immunity induced by immunization with a live, cultured Anaplasma marginale strain.

Authors:  G Kenitra Hammac; Pei-Shin Ku; Maria F Galletti; Susan M Noh; Glen A Scoles; Guy H Palmer; Kelly A Brayton
Journal:  Vaccine       Date:  2013-05-09       Impact factor: 3.641

6.  Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle.

Authors:  María E Primo; Carolina S Thompson; Beatriz S Valentini; Macarena Sarli; María B Novoa; Atilio J Mangold; Susana T de Echaide
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

7.  Mexican Strains of Anaplasma marginale: A First Comparative Genomics and Phylogeographic Analysis.

Authors:  Edgar Dantán-González; Rosa Estela Quiroz-Castañeda; Hugo Aguilar-Díaz; Itzel Amaro-Estrada; Fernando Martínez-Ocampo; Sergio Rodríguez-Camarillo
Journal:  Pathogens       Date:  2022-08-02

Review 8.  Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics Approach.

Authors:  Rosa Estela Quiroz-Castañeda; Itzel Amaro-Estrada; Sergio Darío Rodríguez-Camarillo
Journal:  Biomed Res Int       Date:  2016-08-17       Impact factor: 3.411

9.  A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.

Authors:  Macarena Sarli; María B Novoa; Matilde N Mazzucco; Marcelo L Signorini; Ignacio E Echaide; Susana T de Echaide; María E Primo
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.